Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3.79% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NAGE · Mar 31, 2026
Niagen Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001386570-26-000030General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
3.26% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
76.30% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
63.47% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
5.01% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.45% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 10.43%
- Current
- -3.79%
- Delta
- -14.23%
- Previous
- 29.95%
- Current
- 3.26%
- Delta
- -26.69%
- Previous
- 64.28%
- Current
- 63.47%
- Delta
- -0.81%
- Previous
- 12.58%
- Current
- 5.01%
- Delta
- -7.57%
- Previous
- 4.89%
- Current
- 4.71%
- Delta
- -0.19%
- Previous
- 4.69%
- Current
- 5.45%
- Delta
- 0.76%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · NAGE state analogue 1 →Has State · Niagen Bioscience, Inc. →Transitioned To · NAGE Fundamental State →Transitioned To · NAGE CASH_GENERATION_DECREASED →Transitioned To · NAGE GROWTH_DECREASED →Transitioned To · NAGE MARGIN_DECREASED →Transitioned To · NAGE PROFITABILITY_DECREASED →Transitioned To · NAGE R_AND_D_INTENSITY_DECREASED →Transitioned To · NAGE SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.